Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia.: Subanalysis of the active branch from Czech extended double blind studyEUROPEAN PSYCHIATRYIF6.72020-04-161PREAI
Risperidone long-acting injection in the treatment of recently versus longer diagnosed patients with schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72008-08-010PREAI
Assessing remission in schizophrenia patients treated with long-acting risperidone in clinical practiceEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72008-08-010PREAI
Improvement in personal and social functioning in schizophrenia patients treated with risperidone long acting injection): 6-month results from E-starVALUE IN HEALTHIF62008-05-010OAAI
Treatment outcomes of risperidone long acting injection (RLAI) in schizophrenia: 18-month results from the electronic schizophrenia treatment adherence registry (E-STAR) in Czech Republic and SlovakiaVALUE IN HEALTHIF62008-05-010OAAI
Remission in patients with schizophrenia treated with risperidone long-acting injection:: Results from the e-STAR project in Czech Republic and SlovakiaEUROPEAN PSYCHIATRYIF6.72008-04-010PREAI
Long acting injectable risperidone in the treatment of schizophrenia: 6 month preliminary results in E-star project in Czech RepublicEUROPEAN PSYCHIATRYIF6.72007-03-010PREAI
Metabolic effects of long term treatment with depot neuroleptics and clozapine in patients with schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72003-10-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向